Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 64.19B | 69.30B | 58.61B | 68.45B | 63.86B | 58.64B |
Gross Profit | 62.98B | 43.69B | 58.61B | 68.45B | 63.86B | 58.64B |
EBITDA | 7.89B | 8.46B | 5.52B | 7.06B | 3.81B | 1.98B |
Net Income | 5.09B | 5.68B | 4.61B | 3.43B | 2.93B | 1.21B |
Balance Sheet | ||||||
Total Assets | 275.69B | 286.51B | 273.79B | 298.57B | 312.40B | 297.95B |
Cash, Cash Equivalents and Short-Term Investments | 176.70B | 186.64B | 8.57B | 149.71B | 171.24B | 164.44B |
Total Debt | 6.11B | 6.32B | 4.71B | 6.45B | 6.80B | 6.74B |
Total Liabilities | 244.93B | 253.77B | 244.02B | 277.37B | 281.46B | 267.95B |
Stockholders Equity | 30.58B | 32.64B | 29.65B | 21.06B | 30.83B | 29.89B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 2.83B | 2.40B | -18.32B | 5.23B | 7.22B |
Operating Cash Flow | 0.00 | 3.14B | 2.54B | -7.64B | 5.23B | 7.22B |
Investing Cash Flow | 0.00 | -505.00M | -329.00M | 11.35B | -3.82B | -6.13B |
Financing Cash Flow | 0.00 | -2.23B | -2.98B | -2.70B | -1.68B | -323.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | €31.06B | 12.52 | 19.74% | 3.49% | 7.50% | 22.49% | |
74 Outperform | €36.34B | 13.98 | ― | 2.03% | 1.60% | 19.65% | |
74 Outperform | €139.28B | 13.46 | 16.47% | 4.26% | 47.32% | 17.07% | |
71 Outperform | €72.25B | 14.30 | 16.65% | 3.62% | 2.36% | -11.93% | |
70 Outperform | €58.48B | 9.68 | 4.33% | 2.25% | -4.39% | 81.95% | |
67 Neutral | €28.82B | 12.75 | 16.95% | 2.44% | 6.51% | 22.56% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |